Investors

IR Overview

2017 SITC Annual Meeting

Date/Time
November 8, 2017 through November 12, 2017
Location
Gaylord National Hotel & Convention Center

National Harbor, MD
United States

Description

Trials in Progress Posters:

  • Title: Study Design: Phase 1 dose escalation, multi-tumor study to assess safety, tolerability and antitumor activity of genetically engineered MAGE-A4 SPEAR T-cells in HLA-A2+ subjects with MAGE-A4+ tumors
    -   Poster Number: P247
    -   Session Time: November 10, 2017 from 12:30 PM to 2:00 PM (lunch) and 6:30 PM to 8:00 PM (reception)
    -   Location: Prince George’s Exhibition Hall DE

  • Title: Study Design:  An Open-label Randomized Pilot Study of NY-ESO-1 SPEAR T-cells Alone or in Combination with Pembrolizumab in HLA-A2+ Subjects with Relapsed and Refractory Multiple Myeloma (NCT03168438)
    -   Poster Number: P248
    -   Session Time: November 11, 2017 from 12:30 PM to 2:00 PM (lunch) and 6:30 PM to 8:00 (reception)